David Rodman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Mineralys Therapeutics, Inc. (MLYS)
Source not stated
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | $533,000 | $2,204,704 |
| 2024 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | $520,000 | $2,877,749 |
| 2023 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | $500,000 | $2,334,207 |
| 2022 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | $411,458 | $1,106,507 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.